These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 18695082)

  • 21. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
    Eischer L; Gartner V; Schulman S; Kyrle PA; Eichinger S;
    Ann Hematol; 2009 May; 88(5):485-90. PubMed ID: 18931845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoprotein and the risk of recurrent venous thromboembolism.
    Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH
    Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.
    Martinelli I; Bucciarelli P; Passamonti SM; Battaglioli T; Previtali E; Mannucci PM
    Circulation; 2010 Jun; 121(25):2740-6. PubMed ID: 20547928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population.
    Mello TB; Orsi FL; Montalvao SA; Ozelo MC; de Paula EV; Annichinno-Bizzachi JM
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):660-5. PubMed ID: 20829682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.
    Delluc A; Le Moigne E; Tromeur C; Noel-Savina E; Couturaud F; Mottier D; Le Gal G; Lacut K
    Br J Haematol; 2011 Aug; 154(4):486-91. PubMed ID: 21671893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
    Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
    Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity.
    Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
    Circulation; 2008 Sep; 118(13):1366-72. PubMed ID: 18779446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended treatment for venous thromboembolism: how long is long enough?
    Cosmi B; Palareti G
    Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
    Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
    Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
    Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
    Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.
    Vossen CY; Walker ID; Svensson P; Souto JC; Scharrer I; Preston FE; Palareti G; Pabinger I; van der Meer FJ; Makris M; Fontcuberta J; Conard J; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1992-7. PubMed ID: 15976329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.
    Hoke M; Kyrle PA; Minar E; Bialonzcyk C; Hirschl M; Schneider B; Kollars M; Weltermann A; Eichinger S
    Thromb Haemost; 2005 Oct; 94(4):787-90. PubMed ID: 16270631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.